Smoking cessation opportunities in severe mental illness (tobacco intensive motivational and estimate risk — TIMER—): study protocol for a randomized controlled trial-Reference-Cited by-同舟云学术

Smoking cessation opportunities in severe mental illness (tobacco intensive motivational and estimate risk — TIMER—): study protocol for a randomized controlled trial

Published:2019-01-14 Issue:1 Volume:20 Page:
ISSN:1745-6215
Container-title:Trials
language:en
Short-container-title:Trials

Author:

Jaén-Moreno María José,Feu Nuria,Redondo-Écija Justa,Montiel Francisco Javier,Gómez Cristina,del Pozo Gloria I.,Alcalá Jose Ángel,Gutiérrez-Rojas Luis,Balanzá-Martinez Vicente,Chauca Geli Marie,Carrión Laura,Osuna Maria Isabel,Sánchez María Dolores,Caro Inmaculada,Ayora Miriam,Valdivia Francisca,López María Soledad,Poyato Jose Manuel,Sarramea Fernando

Funder

Instituto de Salud Carlos III

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Medicine (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1186/s13063-018-3139-9.pdf

Reference61 articles.

1. Liu NH, Daumit GL, Dua T, Aquila R, Charlson F, Cuijpers P, et al. Excess mortality in persons with severe mental disorders: a multilevel intervention framework and priorities for clinical practice, policy and research agendas. World Psychiatry. 2017;16(1):30–40.

2. Callaghan RC, Veldhuizen S, Jeysingh T, Orlan C, Graham C, Kakouris G, et al. Patterns of tobacco-related mortality among individuals diagnosed with schizophrenia, bipolar disorder, or depression. J Psychiatr Res. 2014;48(1):102–10.

3. Evins AE, Cather C, Laffer A. Treatment of tobacco use disorders in smokers with serious mental illness: toward clinical best practices. Harv Rev Psychiatry. 2015;23(2):90–8.

4. Garcia-Portilla MP, Bobes J. Smoking cessation programs for persons with schizophrenia: an urgent unmet need. Rev Psiquiatr Salud Ment. 2016;9(4):181–4.

5. Anthenelli RM, Benowitz NL, West R, St Aubin L, McRae T, Lawrence D, et al. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Lancet. 2016;387(10037):2507–20.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cigarette smoking and risk of suicide in bipolar disorder: a systematic review;Frontiers in Psychiatry;2023-05-19

2. Chronic obstructive pulmonary disease in severe mental illness: A timely diagnosis to advance the process of quitting smoking;European Psychiatry;2021

3. The Acceptability and Feasibility of Using Text Messaging to Support the Delivery of Physical Health Care in those Suffering from a Psychotic Disorder: a Review of the Literature;Psychiatric Quarterly;2020-09-24